Found: 11
Select item for more details and to access through your institution.
Exploratory analysis of the effect of a dexamethasone-sparing regimen for prophylaxis of cisplatin-induced emesis on food intake (LUNG-NEPA study).
- Published in:
- Scientific Reports, 2022, v. 13, n. 1, p. 1, doi. 10.1038/s41598-023-28464-9
- By:
- Publication type:
- Article
Exploratory analysis of the effect of a dexamethasone-sparing regimen for prophylaxis of cisplatin-induced emesis on food intake (LUNG-NEPA study).
- Published in:
- Scientific Reports, 2023, v. 13, n. 1, p. 1, doi. 10.1038/s41598-023-28464-9
- By:
- Publication type:
- Article
Integration of Lipidomics and Transcriptomics Reveals Reprogramming of the Lipid Metabolism and Composition in Clear Cell Renal Cell Carcinoma.
- Published in:
- Metabolites (2218-1989), 2020, v. 10, n. 12, p. 509, doi. 10.3390/metabo10120509
- By:
- Publication type:
- Article
U-CHANGE Project: a multidimensional consensus on how clinicians, patients and caregivers may approach together the new urothelial cancer scenario.
- Published in:
- Frontiers in Oncology, 2023, p. 01, doi. 10.3389/fonc.2023.1186103
- By:
- Publication type:
- Article
U-CHANGE Project: a multidimensional consensus on how clinicians, patients and caregivers may approach together the new urothelial cancer scenario.
- Published in:
- Frontiers in Oncology, 2023, p. 1, doi. 10.3389/fonc.2023.1186103
- By:
- Publication type:
- Article
Statins activate the mitochondrial pathway of apoptosis in human lymphoblasts and myeloma cells.
- Published in:
- Carcinogenesis, 2005, v. 26, n. 5, p. 883, doi. 10.1093/carcin/bgi036
- By:
- Publication type:
- Article
Playing the Devil's Advocate: Should We Give a Second Chance to mTOR Inhibition in Renal Clear Cell Carcinoma? – ie Strategies to Revert Resistance to mTOR Inhibitors.
- Published in:
- Cancer Management & Research, 2021, v. 13, p. 7623, doi. 10.2147/CMAR.S267220
- By:
- Publication type:
- Article
Evaluating the impact of chemotherapy-induced nausea and vomiting on daily functioning in patients receiving dexamethasone-sparing antiemetic regimens with NEPA (netupitant/palonosetron) in the cisplatin setting: results from a randomized phase 3 study.
- Published in:
- 2022
- By:
- Publication type:
- journal article
Central nervous system metastases from castration-resistant prostate cancer in the docetaxel era.
- Published in:
- Journal of Neuro-Oncology, 2012, v. 107, n. 1, p. 191, doi. 10.1007/s11060-011-0734-y
- By:
- Publication type:
- Article
Dexamethasone‐Sparing Regimens with Oral Netupitant and Palonosetron for the Prevention of Emesis Caused by High‐Dose Cisplatin: A Randomized Noninferiority Study.
- Published in:
- Oncologist, 2021, v. 26, n. 10, p. e1854, doi. 10.1002/onco.13851
- By:
- Publication type:
- Article
Molecular alterations of IL-6R, lck and c-myc genes in transforming monoclonal gammopathies of undetermined significance.
- Published in:
- British Journal of Haematology, 1996, v. 93, n. 3, p. 623, doi. 10.1046/j.1365-2141.1996.d01-1685.x
- By:
- Publication type:
- Article